Reasoning that alanine supplementation resulted in GPT1 overexpression, we treated the alanine-supplemented HCC cells with aminooxyacetate (AOA), a general inhibitor of enzymatic activity of transaminase [19]. Here, GPT is linked to hepatocellular carcinoma.